Table of Contents

CAFC Precedential - 2025 - AIA Proceedings

IPR Procedure

- In re Gesture 25-1075.pdf

- Centripetal 23-2027.pdf

In an obviousness analysis, the Board must consider all properly presented evidence of secondary considerations (including copying) and assign it whatever weight the evidence warrants; it is reversible error to omit discussion of such evidence on the ground that the Board is not positioned to evaluate the broader litigation record.

Jurisdiction

- Mitek Systems 23-1687.pdf

IPR Institution

IGT v. Zynga: Decision not to apply interference estoppel as a bar to institution is nonappealable

The Federal Circuit held that the PTO's decision not to apply interference estoppel as a bar to institution is a nonappealable institution determination under 35 U.S.C. § 314(d), with no Cuozzo “shenanigans” exception on these facts. The court also rejected a procedural challenge that the Board relied on a new, unargued unpatentability theory, finding adequate notice and opportunity to respond under IPR due-process/APA principles.

Read more

Estoppel, Time Bars, Jurisdiction

- Appl 23-1475.pdf

- In re Gesture 25-1075.pdf

- Ingenico 23-1367.pdf

Evidence, Burdens, and Standards

- Alivecor 23-1512.pdf

- Amp Plus 23-1997.pdf

- Apple 23-1501.pdf

- Centripetal 23-2027.pdf

- Dolby 23-2110.pdf

- Global Health 23-2009.pdf

- Honeywell 23-1354.pdf

- IBM 24-1170.pdf

- In re PT Medisafe Tech. 23-1573.pdf [NEEDS_REVIEW]

- Kroy IP 23-1359.pdf

- Lashify 23-1245.pdf

- Lynk Labs 23-2346.pdf

- Merck 25-1210.pdf

- Shockwave Medical 23-1864.pdf

AIA Merits: §§ 102, 103, 112

AMP Plus v. DMF: Appellant raised new grounds and presented inadequate analysis.

The Federal Circuit affirmed PTAB's opinion on remand that ELCO failed to show unpatentability of claim 22 because:

Read more

- Ancora 23-1674.pdf

- Appl 23-1475.pdf

- Apple 23-1501.pdf

- Bayer Pharma 23-2434.pdf

- Causam 24-1958.pdf

- Global Health 23-2009.pdf

- HD Silicon 23-1397.pdf

- Honeywell 23-1354.pdf

- IBM 24-1170.pdf

- IGT 23-2262.pdf

- Kroy IP 23-1359.pdf

- Lynk Labs 23-2346.pdf

- Qualcomm 23-1208.pdf

- Restem 23-2054.pdf

- Shockwave Medical 23-1864.pdf

AIA_PROCEDURE_DUE_PROCESS_APA

- Alivecor 23-1512.pdf

- Amp Plus 23-1997.pdf

- Appl 23-1475.pdf

- CQV 23-1027.pdf

- Causam 24-1958.pdf

- Centripetal 23-2027.pdf

- Honeywell 23-1354.pdf

- IBM 24-1170.pdf

- IGT 23-2262.pdf

- In re Bayou Grand Coffee 24-1118.pdf [NEEDS_REVIEW]

- In re Riggs 22-1945.pdf

- Merck 25-1210.pdf

- Odyssey Logistics 23-2077.pdf

- Qualcomm 23-1208.pdf

- Sage Products 23-1603.pdf

- Shockwave Medical 23-1864.pdf